Acutus Medical, Inc.
AFIB
$0.0302
-$0.0106-25.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 20.15M | 15.37M | 12.16M | 9.55M | 7.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.15M | 15.37M | 12.16M | 9.55M | 7.17M |
| Cost of Revenue | 19.14M | 15.49M | 13.74M | 11.80M | 10.25M |
| Gross Profit | 1.00M | -119.00K | -1.58M | -2.25M | -3.09M |
| SG&A Expenses | 10.44M | 12.44M | 12.48M | 13.54M | 14.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.58M | 28.66M | 27.85M | 27.88M | 28.41M |
| Operating Income | -9.43M | -13.29M | -15.69M | -18.33M | -21.24M |
| Income Before Tax | -4.54M | -5.21M | -6.32M | -10.19M | -12.41M |
| Income Tax Expenses | -- | 63.00K | 63.00K | 63.00K | 63.00K |
| Earnings from Continuing Operations | -4.54 | -5.28 | -6.38 | -10.25 | -12.48 |
| Earnings from Discontinued Operations | -5.00M | -36.63M | -43.16M | -56.72M | -69.19M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.55M | -41.91M | -49.54M | -66.97M | -81.66M |
| EBIT | -9.43M | -13.29M | -15.69M | -18.33M | -21.24M |
| EBITDA | -9.14M | -13.01M | -15.32M | -17.90M | -20.81M |
| EPS Basic | -0.32 | -1.43 | -1.69 | -2.29 | -2.80 |
| Normalized Basic EPS | -0.29 | -0.35 | -0.38 | -0.45 | -0.46 |
| EPS Diluted | -0.32 | -1.43 | -1.69 | -2.29 | -2.80 |
| Normalized Diluted EPS | -0.29 | -0.35 | -0.38 | -0.45 | -0.46 |
| Average Basic Shares Outstanding | 118.98M | 118.52M | 117.99M | 117.30M | 116.38M |
| Average Diluted Shares Outstanding | 118.98M | 118.52M | 117.99M | 117.30M | 116.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |